Brister Mark 4
4 · OBALON THERAPEUTICS INC · Filed Aug 27, 2018
Insider Transaction Report
Form 4
Brister Mark
Chief Technology Officer
Transactions
- Award
Common Stock
[F1][F2]2018-08-23$1.82/sh+107,142$194,998→ 338,634 total
Footnotes (2)
- [F1]The reporting person purchased these shares directly from the issuer in a private placement.
- [F2]Includes Restricted Shares that are subject to vesting.
Signature
/s/ Nooshin Hussainy as attorney-in-fact for Mark Brister|2018-08-27